EN
enGene Holdings Inc. (ENGN)
NASDAQ·Healthcare·Biotechnology
$1.76
+4.46%
Mkt Cap $115.27M
Analyst Ratings
Buy
2
Hold
1
Sell
1
Price Target (14 analysts)
$3.00
Range $2.00 – $4.00
Implied Upside
+70.9%
Consensus $3.00 vs current $1.76
NASDAQ·Healthcare·Biotechnology
$1.76
+4.46%
Mkt Cap $115.27M
Buy
2
Hold
1
Sell
1
Price Target (14 analysts)
$3.00
Range $2.00 – $4.00
+70.9%
Consensus $3.00 vs current $1.76